The Science of Prevention: Novel Strategies for and New Insights Into Central Nervous System Prophylaxis in Patients With CancerGLANTZ, Michael; RECHT, Lawrence.Seminars in oncology. 2009, Vol 36, Num 4, issn 0093-7754, 77 p., SUP2Conference Proceedings

Optimizing therapy for patients with brain metastasesKUO, Timothy; RECHT, Lawrence.Seminars in oncology. 2006, Vol 33, Num 3, pp 299-306, issn 0093-7754, 8 p.Article

Understanding the Origins of Gliomas and Developing Novel Therapies: Cerebrospinal Fluid and Subventricular Zone InterplayGLANTZ, Michael; KESARI, Santosh; RECHT, Lawrence et al.Seminars in oncology. 2009, Vol 36, Num 4, issn 0093-7754, S17-S24, SUP2Conference Paper

Neurologic complications of hematologic neoplasmsRECHT, Lawrence; MRUGALA, Maciej.Neurologic clinics. 2003, Vol 21, Num 1, issn 0733-8619, viii, 87-105 [20 p.]Article

Statistical and Trial Design Considerations in Central Nervous System Prophylaxis StudiesSMITH, Jennifer A; GLANTZ, Michael.Seminars in oncology. 2009, Vol 36, Num 4, issn 0093-7754, S69-S76, SUP2Conference Paper

Central Nervous System Disease in Hematologic Malignancies: Historical Perspective and Practical ApplicationsPUI, Ching-Hon; THIEL, Eckhard.Seminars in oncology. 2009, Vol 36, Num 4, issn 0093-7754, S2-S16, SUP2Conference Paper

A distinct phenotypic change in gliomas at the time of magnetic resonance imaging detection : Laboratory investigationTAICHANG JANG; SATHY, Binulal; HSU, Yi-Hua et al.Journal of neurosurgery. 2008, Vol 108, Num 4, pp 782-790, issn 0022-3085, 9 p.Article

Diagnostic Tools for Neoplastic Meningitis: Detecting Disease, Identifying Patient Risk, and Determining Benefit of TreatmentCHAMBERLAIN, Marc C; GLANTZ, Michael; GROVES, Morris D et al.Seminars in oncology. 2009, Vol 36, Num 4, issn 0093-7754, S35-S45, SUP2Conference Paper

Osteopontin expression in intratumoral astrocytes marks tumor progression in gliomas induced by prenatal exposure to N-ethyl-N-nitrosoureaTAICHANG JANG; SAVARESE, Todd; RECHT, Lawrence et al.The American journal of pathology. 2006, Vol 168, Num 5, pp 1676-1685, issn 0002-9440, 10 p.Article

5'-AMP-activated protein kinase activity is elevated early during primary brain tumor development in the ratTAICHANG JANG; CALAOAGAN, Joy M; KWON, Eunice et al.International journal of cancer (Print). 2011, Vol 128, Num 9, pp 2230-2239, issn 0020-7136, 10 p.Article

Gender Disparity in the Rate of Partner Abandonment in Patients With Serious Medical IllnessGLANTZ, Michael J; CHAMBERLAIN, Marc C; QIN LIU et al.Cancer. 2009, Vol 115, Num 22, pp 5237-5242, issn 0008-543X, 6 p.Article

Treatment Modalities for Leptomeningeal MetastasesSHAPIRO, William R; JOHANSON, Conrad E; BOOGERD, Willem et al.Seminars in oncology. 2009, Vol 36, Num 4, issn 0093-7754, S46-S54, SUP2Conference Paper

Steroid-Sparing Effect of Corticorelin Acetate in Peritumoral Cerebral Edema Is Associated With Improvement in Steroid-Induced MyopathyRECHT, Lawrence; MECHTLER, Laszlo L; WONG, Eric T et al.Journal of clinical oncology. 2013, Vol 31, Num 9, pp 1182-1187, issn 0732-183X, 6 p.Article

Should Intra-cerebrospinal Fluid Prophylaxis Be Part of Initial Therapy for Patients With Non-Hodgkin Lymphoma: What We Know, and How We Can Find Out MoreHERRLINGER, Ulrich; GLANTZ, Michael; SCHLEGEL, Uwe et al.Seminars in oncology. 2009, Vol 36, Num 4, issn 0093-7754, S25-S34, SUP2Conference Paper

The Role of Intra-cerebrospinal Fluid Treatment and Prophylaxis in Patients With Solid TumorsSOFFIETTI, Riccardo; AKERLEY, Wallace; JENSEN, Randy L et al.Seminars in oncology. 2009, Vol 36, Num 4, issn 0093-7754, S55-S68, SUP2Conference Paper

Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomasGLANTZ, Michael; CHAMBERLAIN, Marc; QIN LIU et al.Cancer. 2003, Vol 97, Num 9, pp 2262-2266, issn 0008-543X, 5 p.Article

High-resolution genome-wide mapping of genetic alterations in human glial brain tumorsBREDEL, Markus; BREDEL, Claudia; JURIC, Dejan et al.Cancer research (Baltimore). 2005, Vol 65, Num 10, pp 4088-4096, issn 0008-5472, 9 p.Article

Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-lnteracting genes in human gliomasBREDEL, Markus; BREDEL, Claudia; JURIC, Dejan et al.Cancer research (Baltimore). 2005, Vol 65, Num 19, pp 8679-8689, issn 0008-5472, 11 p.Article

Embryonic stem cell rescue of tremor and ataxia in myelin-deficient shiverer miceHOI PANG LOW; GRECO, Béatrice; TANAHASHI, Yusuke et al.Journal of the neurological sciences. 2009, Vol 276, Num 1-2, pp 133-137, issn 0022-510X, 5 p.Article

Antitumor effects of ajulemic acid (CT3), a synthetic non-psychoactive cannabinoidRECHT, Lawrence D; SALMONSEN, Rebecca; BURSTEIN, Sumner et al.Biochemical pharmacology. 2001, Vol 62, Num 6, pp 755-763, issn 0006-2952Article

Tumor necrosis factor-α-induced protein 3 as a putative regulator of nuclear factor- κB-mediated resistance to O⁶-alkylating agents in human glioblastomasBREDEL, Markus; BREDEL, Claudia; JURIC, Dejan et al.Journal of clinical oncology. 2006, Vol 24, Num 2, pp 274-287, issn 0732-183X, 14 p.Article

Association of increased phosphatidylinositol 3-kinase signaling with increased invasiveness and gelatinase activity in malignant gliomasKUBIATOWSKI, Tomas; TAICHANG JANG; LACHYANKAR, Mahesh B et al.Journal of neurosurgery. 2001, Vol 95, Num 3, pp 480-488, issn 0022-3085Article

Isolation of immortalized, INK4a/ARF-deficient cells from the subventricular zone after in utero N-ethyl-N-nitrosourea exposureSAVARESE, Todd M; TAICHANG JANG; LOW, Hoi Pang et al.Journal of neurosurgery. 2005, Vol 102, Num 1, pp 98-108, issn 0022-3085, 11 p.Article

A method for clonal analysis of epidermal growth factor-responsive neural progenitorsENGSTROM, Caron M; DEMERS, Delia; RECHT, Lawrence D et al.Journal of neuroscience methods. 2002, Vol 117, Num 2, pp 111-121, issn 0165-0270Article